GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine – PR Newswire (press release)

GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for EzogabinePR Newswire (press release)For further information please visit www.gsk.com Valeant Pharmaceuticals – Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty …and more »